Dr. Carol Ash, DO

NPI: 1750484341
Total Payments
$7,885
2024 Payments
$16.00
Companies
5
Transactions
19
Medicare Patients
42
Medicare Billing
$11,735

Payment Breakdown by Category

Other$6,930 (87.9%)
Food & Beverage$729.72 (9.3%)
Travel$225.00 (2.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $6,930 3 87.9%
Food and Beverage $729.72 13 9.3%
Travel and Lodging $225.00 3 2.9%

Top Paying Companies

Company Total Records Latest Year
Merck Sharp & Dohme Corporation $7,465 9 $0 (2017)
Boehringer Ingelheim Pharmaceuticals, Inc. $353.70 5 $0 (2023)
Janssen Pharmaceuticals, Inc $26.75 2 $0 (2019)
Allergan Inc. $23.74 2 $0 (2017)
Novartis Pharmaceuticals Corporation $16.00 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $16.00 1 Novartis Pharmaceuticals Corporation ($16.00)
2023 $21.82 1 Boehringer Ingelheim Pharmaceuticals, Inc. ($21.82)
2022 $12.27 1 Boehringer Ingelheim Pharmaceuticals, Inc. ($12.27)
2021 $319.61 3 Boehringer Ingelheim Pharmaceuticals, Inc. ($319.61)
2019 $13.56 1 Janssen Pharmaceuticals, Inc ($13.56)
2018 $13.19 1 Janssen Pharmaceuticals, Inc ($13.19)
2017 $7,488 11 Merck Sharp & Dohme Corporation ($7,465)

All Payment Transactions

19 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
03/29/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $16.00 General
Category: Cardiology/Vascular Diseases
04/14/2023 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $21.82 General
03/31/2022 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $12.27 General
07/22/2021 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $95.01 General
06/15/2021 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $105.22 General
06/01/2021 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $119.38 General
09/05/2019 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $13.56 General
Category: Cardiovascular & Metabolism
09/20/2018 Janssen Pharmaceuticals, Inc XARELTO (Drug), XARELTO Food and Beverage In-kind items and services $13.19 General
Category: Cardiovascular & Metabolism
08/22/2017 Merck Sharp & Dohme Corporation BELSOMRA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,310.00 General
Category: NEUROSCIENCE
08/22/2017 Merck Sharp & Dohme Corporation BELSOMRA (Drug) Travel and Lodging Cash or cash equivalent $75.00 General
Category: NEUROSCIENCE
08/16/2017 Merck Sharp & Dohme Corporation BELSOMRA (Drug) Food and Beverage In-kind items and services $99.07 General
Category: NEUROSCIENCE
06/13/2017 Merck Sharp & Dohme Corporation BELSOMRA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,310.00 General
Category: NEUROSCIENCE
06/13/2017 Merck Sharp & Dohme Corporation BELSOMRA (Drug) Travel and Lodging Cash or cash equivalent $75.00 General
Category: NEUROSCIENCE
06/07/2017 Merck Sharp & Dohme Corporation BELSOMRA (Drug) Food and Beverage In-kind items and services $92.78 General
Category: NEUROSCIENCE
04/18/2017 Allergan Inc. ESTRACE CREAM (Drug) Food and Beverage In-kind items and services $10.80 General
Category: WOMENS HEALTH
03/07/2017 Merck Sharp & Dohme Corporation BELSOMRA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,310.00 General
Category: NEUROSCIENCE
03/07/2017 Merck Sharp & Dohme Corporation BELSOMRA (Drug) Travel and Lodging Cash or cash equivalent $75.00 General
Category: NEUROSCIENCE
03/01/2017 Allergan Inc. ESTRACE CREAM (Drug) Food and Beverage In-kind items and services $12.94 General
Category: WOMENS HEALTH
02/28/2017 Merck Sharp & Dohme Corporation BELSOMRA (Drug) Food and Beverage In-kind items and services $117.68 General
Category: NEUROSCIENCE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 1 18 31 $41,559 $5,489
2021 1 24 31 $41,559 $6,246
Total Patients
42
Total Services
62
Medicare Billing
$11,735
Procedure Codes
2

All Medicare Procedures & Services

2 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99291 Critical care, first 30-74 minutes Facility 2023 18 31 $41,559 $5,489 13.2%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2021 24 31 $41,559 $6,246 15.0%

About Dr. Carol Ash, DO

Dr. Carol Ash, DO is a Sleep Medicine healthcare provider based in Red Bank, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750484341.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carol Ash, DO has received a total of $7,885 in payments from pharmaceutical and medical device companies, with $16.00 received in 2024. These payments were reported across 19 transactions from 5 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($6,930).

As a Medicare-enrolled provider, Ash has provided services to 42 Medicare beneficiaries, totaling 62 services with total Medicare billing of $11,735. Data is available for 2 years (2021–2023), covering 2 distinct procedure/service records.

Practice Information

  • Specialty Sleep Medicine
  • Other Specialties Critical Care Medicine
  • Location Red Bank, NJ
  • Active Since 09/07/2006
  • Last Updated 09/28/2016
  • Taxonomy Code 207RS0012X
  • Entity Type Individual
  • NPI Number 1750484341

Products in Payments

  • BELSOMRA (Drug) $7,465
  • XARELTO (Drug) $26.75
  • ESTRACE CREAM (Drug) $23.74
  • LEQVIO (Drug) $16.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.